Glucagon-like peptide-1 receptor agonists for diabetes mellitus: a role in cardiovascular disease

Circulation. 2014 Jun 3;129(22):2305-12. doi: 10.1161/CIRCULATIONAHA.113.006985.
No abstract available

Keywords: cardiovascular diseases; diabetes mellitus; obesity; pharmaceutical preparations; prevention & control.

Publication types

  • Review

MeSH terms

  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Glucagon-Like Peptide-1 Receptor
  • Glycated Hemoglobin / drug effects
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Incretins / physiology
  • Receptors, Glucagon / agonists*
  • Receptors, Glucagon / drug effects
  • Risk Factors

Substances

  • Blood Glucose
  • GLP1R protein, human
  • Glucagon-Like Peptide-1 Receptor
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Incretins
  • Receptors, Glucagon